12.01.14
Officials with Zimmer Holdings Inc. said that once the deal for its Warsaw, Ind.-based neighbor Biomet Inc. closes, the newly combined firm will be called Zimmer Biomet.
In April, Zimmer executives announced plans to acquire privately held Biomet in a cash-and-stock deal worth $13.35 billion including Biomet’s debt. Zimmer shareholders will own about 84 percent of the combined company.
Zimmer officials said the new company will have three divisions: a knee and hip device and bone cement business; a sports medicine, extremities, trauma products, biologic devices, and surgical items business; and a spinal, craniomaxillofacial, dental implants and bone healing products business.
Daniel Florin will be the company’s chief financial officer (CFO). Florin has been CFO of Biomet for seven years. Zimmer CFO James Crines will retire following the close of the deal, but will continue to advise the company.
Zimmer President/CEO David Dvorak will continue to lead the combined company.
“These announcements mark important milestones that will help advance the effective integration of our two companies upon closing,” said Dvorak. “Zimmer and Biomet each have extraordinary talent across all levels, and we are confident that we have put in place a team and organizational structure to drive the combined company into this new chapter.”
Other Zimmer Biomet business units and leadership will include the following:
In April, Zimmer executives announced plans to acquire privately held Biomet in a cash-and-stock deal worth $13.35 billion including Biomet’s debt. Zimmer shareholders will own about 84 percent of the combined company.
Zimmer officials said the new company will have three divisions: a knee and hip device and bone cement business; a sports medicine, extremities, trauma products, biologic devices, and surgical items business; and a spinal, craniomaxillofacial, dental implants and bone healing products business.
Daniel Florin will be the company’s chief financial officer (CFO). Florin has been CFO of Biomet for seven years. Zimmer CFO James Crines will retire following the close of the deal, but will continue to advise the company.
Zimmer President/CEO David Dvorak will continue to lead the combined company.
“These announcements mark important milestones that will help advance the effective integration of our two companies upon closing,” said Dvorak. “Zimmer and Biomet each have extraordinary talent across all levels, and we are confident that we have put in place a team and organizational structure to drive the combined company into this new chapter.”
Other Zimmer Biomet business units and leadership will include the following:
- Adam R. Johnson, group president, with responsibility for the spine, microfixation, bone healing and dental business. Johnson has served in leadership roles at Biomet for 12 years and currently leads Biomet’s Spine, Microfixation and Bone Healing Division.
- David A. Nolan, group president, with responsibility for the sports medicine, extremities, trauma, biologics and surgical business. Nolan has more than 20 years of experience in commercial leadership roles at Biomet and Zimmer; he currently heads Zimmer’s Advanced Solutions portfolio.
- Daniel E. Williamson, group president, with responsibility for the knee, hip and bone cement business. Williamson has served in senior leadership roles at Biomet for 24 years and currently heads Biomet’s Reconstructive Division.
- Stuart G. Kleopfer, president, Americas. The Americas region will comprise the United States, Canada and Latin America. Kleopfer has held the U.S. executive leadership position at Biomet for four years and has been with Biomet for 26 years.
- Katarzyna Mazur-Hofsaess, M.D., Ph.D., president, EMEA. The EMEA region will be composed of Europe, the Middle East and Africa. Mazur-Hofsaess has held an EMEA senior leadership position with Zimmer for four years.
- Sang Yi, president, Asia-Pacific. The Asia-Pacific region will comprise China, Japan, India, Australia, New Zealand, Korea and Southeast Asia. Yi has held an Asia-Pacific executive leadership position with Zimmer for two years. Stephen H.L. Ooi, Zimmer’s current president of Asia-Pacific, will retire and serve in an advisory role once the deal closes.
- Robin T. Barney, senior vice president, Global Operations and Logistics. Barney has held the Global Operations and Logistics executive position at Biomet for seven years.
- Audrey M. Beckman, senior vice president, Strategic Quality Initiatives. Beckman has served in senior leadership roles at Zimmer for 18 years and has been with the company for 28 years.
- William P. Fisher, senior vice president, Global Human Resources. Fisher has held the Global Human Resources executive position at Zimmer for five years.
- Emmanuel O. Nyakako, senior vice president, Global Quality, Clinical and Regulatory Affairs. Nyakako has held the Global Quality, Clinical and Regulatory Affairs executive position at Zimmer for two years.
- Chad F. Phipps, senior vice president, General Counsel and Secretary. Phipps has held the General Counsel position at Zimmer for seven years.